RAC 0.00% $1.59 race oncology ltd

General Comments / Chat, page-10959

  1. 8 Posts.
    lightbulb Created with Sketch. 3
    Very good presentation.

    Connecting a couple of dots from a couple of slides
    1/ Point 4: “Low cost development with an opportunity for a rapid pathway to market via the FDA accelerated approval process from Phase 2”
    2/ Timeline has Phase 2 in 2026

    We all know big numbers can come at any time but the biggest will come likely 2027.

    Patients. Patents. Patience.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.